drugset / Trial / NCT03713216
Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the effect and safety of NALDEBAIN versus Morphine as needed in patients after laparoscopic cholecystectomy.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2019-10-01
- Completion
- 2020-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinalbuphine sebacate | Small molecule | 150 mg | Intramuscular |
| Comparator | Morphine | Other / unclassified | — | — |
Indications
No indication recorded.